Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …
Traces of the medicine and personal care products are winding up in the rivers, lakes, and oceans through sewage, potentially affecting aquatic environments, scientists say. Researchers from Rutgers University in the US found that bacteria in sewage treatment plants may be creating new contaminants that have not been evaluated for …
A mosquito-killing drug tested in Burkina Faso reduced malaria cases by a fifth among children and could be an important new tool in the global fight against the disease, researchers said. The drug, ivermectin, is already widely used to treat parasitic infections but had not previously been tested for its …
Doctors said on Wednesday that patients in Zimbabwe's biggest state hospital were dying due to a lack of medicines and basic supplies, brought on by a cash crunch that has crippled the economy. In a rare protest by senior medical staff, dozens of doctors picketed outside Parirenyatwa Hospital. They said …
Many people living with HIV in rural areas are developing drug resistance due to lack of access to their daily antiretroviral drugs (ARVs), lack of food and drug stock-outs and shortages. Some of the patients especially in rural areas lack the transport to take them to health centres to pick …
JAIPUR: To boost free medicine scheme in the state, the health department has approved contractual recruitment of around more than 3,700 employees for the financial year 2019-20. Ever since Ashok Gehlot-led government came into power in the state, health department has been taking measures to provide momentum to the free …
NEW DELHI: Antimicrobial Resistance (AMR) has been identified as one of the 10 threats to global health in 2019 by World Health Organisation (WHO). The other threats on this list include HIV, Ebola, dengue, vaccine hesitancy, air pollution and climate change. The health organisation has warned that if action is …
NEW DELHI: The health ministry was actively mulling compulsory licensing, apart from price capping, of “orphan drugs” (for rare diseases), when the department of pharmaceuticals abruptly issued an order exempting such medicines from price control, derailing plans to make these drugs affordable. The health ministry discussed price capping and invoking …
President Maithripala Sirisena has ordered officials to prepare a plan in the new year to alleviate poverty in the country. Addressing public officials at the Polonnaruwa District Secretariat, the President emphasised the need to eliminate the drug menace and bolster projects that were already underway to tackle the drug menace. …
The Ministry of Health of the Democratic Republic of the Congo (DRC) today announced that a randomized control trial has begun to evaluate the effectiveness and safety of drugs used in the treatment of Ebola patients. The trial is the first-ever multi drug trial for an Ebola treatment. It will …
The Indian government proposes to eliminate kala-azar, which has been a serious public health problem in Bihar. This study aimed to assess the magnitude of unresponsiveness to sodium stibogluconate in the treatment of new cases of visceral leishmaniasis and to identify the associated factors.
The Access to Medicine Index finds that a handful of pharmaceutical companies are developing the bulk of urgently needed new medicines for the poor. The development of new medical products that are considered the highest priority for people in developing countries is highly concentrated - among five pharmaceutical companies and …
Uganda has started recruiting women for trials of a long-lasting injectable antiretroviral drug for Pre-Exposure Prophylaxis. This is part of a large scale trial that will also be conducted in six other countries — Kenya, Malawi, Botswana, Zimbabwe, South Africa and Swaziland. A total of 3,200 individuals are expected to …
Many of the world's top drugmakers are not doing enough to provide medicines to poor countries, leaving big gaps in access to treatments in crucial disease areas, including cancer, according to a new report on Tuesday. The non-profit Access to Medicine Foundation (AMF) found companies overall were doing more than …
Despite the urgent need for new, effective antibiotics, few antibiotics of value have entered the market during the past decades. Therefore, incentives have been developed to stimulate antibiotic R&D. For these incentives to be effective, geographic availability for recently approved antibiotics needs to be better understood. In this study, we …
Order of the Supreme Court of India in the matter of All India Drug Action Network & Others Vs Union of India & Others dated 10/10/2018 regarding Drug Price Control Order 2013. Counsel for the All India Drug Action Network in 2015 had confined his submission to four major issues …
The morbidity and socioeconomic effects of onchocerciasis, a parasitic disease that is primarily endemic in sub-Saharan Africa, have motivated large morbidity and transmission control programmes. Annual communitydirected ivermectin treatment has substantially reduced prevalence. Elimination requires intensified efforts, including more efficacious treatments. We compared parasitological efficacy and safety of moxidectin and …
India accounted for 27 per cent of the 10 million people who developed tuberculosis in 2017, the highest among the top 30 high TB burden countries in the world, according to this WHO report The 2018 edition of the Global Tuberculosis Report, provides a comprehensive and up-to-date assessment of the …
Judgement of the Supreme Court of India in the matter of Pankaj Sinha Vs Union of India & Others dated 14/09/2018 regarding determination of new cases of leprosy and to publish and bring in the public domain the reports of National Sample Survey on Leprosy conducted in 2010-2011 and further …
Order of the Supreme Court of India in the matter of Swasthya Adhikar Manch & Others Vs Union of India & Others dated 12/09/2018 regarding Draft Drugs and Clinical Trials Rules 2018. The Government of India has issued Drugs and Clinical Trials Rules, 2018 in February, 2018. The Draft Rules …
Understanding of the factors driving global antimicrobial resistance is limited. We analysed antimicrobial resistance and antibiotic consumption worldwide versus many potential contributing factors. Original Source
